Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.